Nicholas Fernandez - 30 Apr 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)

Role
Director
Signature
/s/ Nicholas Fernandez
Issuer symbol
LIMN
Transactions as of
30 Apr 2025
Net transactions value
$0
Form type
3
Filing time
30 Apr 2025, 18:28:03 UTC

No securities are beneficially owned.